Table 3.
Allele | Predicted peptide | IC50 (nM) | MHC restriction | Number of polymorphic sites |
---|---|---|---|---|
T-cell epitopes | ||||
Class I | ||||
HLA-A*23:01 | KYLFIPSHNSFI | 9.08 | 0 | |
HLA-A*30:01 | KIKLNIWRTFQK | 16.15 | 0 | |
HLA-B*35:01 | YTFLDYYKHLSY | 19.23 | 0 | |
HLA-B*35:01 | FVIIPHYTFLDY | 22.85 | 0 | |
HLA-A*30:01 | GIRYHYDEYIHK | 24.39 | 0 | |
HLA-A*02:01 | ILQEKEGHLDFV | 27.43 | 0 | |
HLA-A*23:01 | TYGKCIAVDAFI | 38.75 | 1 | |
HLA-A*30:01 | KTNNAKDHSTYI | 44.27 | 0 | |
Class II | ||||
DRB1_1304 | KLILSVKSKNLN | 33.82 | 1 | |
SYIYIDTIKFIH | 35.44 | 2 | ||
HKLILSVKSKNL | 36.13 | 1 | ||
TNILQQSELLLT | 40.87 | 0 | ||
GSYIYIDTIKFI | 43.09 | 2 | ||
IKFIHKEMKHIF | 43.28 | 1 | ||
SELLLTNLNKKM | 44.77 | 0 | ||
TKIINDKTKIIQ | 45.48 | 0 | ||
DRB1_0701 | KYLFIPSHNSFI | 32.95 | 0 | |
YLFIPSHNSFIK | 39.41 | 0 | ||
KLILSVKSKNLN | 40.14 | 1 | ||
HKLILSVKSKNL | 44.98 | 1 | ||
SNYNIANSIDIL | 49.01 | 0 | ||
DRB1_1101 | YIHKLILSVKSK | 29.07 | 1 | |
HKLILSVKSKNL | 30.62 | 1 | ||
KLILSVKSKNLN | 33.20 | 1 | ||
LKYLFIPSHNSF | 35.97 | 0 | ||
EYIHKLILSVKS | 34.24 | 1 | ||
KYLFIPSHNSFI | 41.07 | 0 | ||
IHKLILSVKSKN | 41.24 | 1 | ||
IKFIHKEMKHIF | 44.58 | 1 | ||
DRB1_0120 | KYLFIPSHNSFI | 8.430 | 0 | |
KLILSVKSKNLN | 8.80 | 1 | ||
LKYLFIPSHNSF | 9.77 | 0 | ||
HKLILSVKSKNL | 11.39 | 0 | ||
LILSVKSKNLNK | 11.66 | 1 | ||
GLKYLFIPSHNS | 12.49 | 0 | ||
YLFIPSHNSFIK | 12.23 | 0 | ||
B-cell epitopes | ||||
KKYSVFNQINDG | 1 | |||
DSYRYDISEEID | 0 | |||
EIDNDKENIKTN | 1 |